PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 93 filers reported holding PMV PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,196 | -44.3% | 34,071 | -43.2% | 0.00% | 0.0% |
| Q2 2023 | $375,694 | -42.5% | 60,015 | -56.2% | 0.00% | -50.0% |
| Q1 2023 | $653,252 | +436.3% | 136,950 | +878.2% | 0.00% | – |
| Q4 2022 | $121,800 | -64.0% | 14,000 | -50.7% | 0.00% | -100.0% |
| Q3 2022 | $338,000 | -63.9% | 28,400 | -36.7% | 0.00% | -66.7% |
| Q1 2022 | $935,000 | -85.1% | 44,900 | -83.5% | 0.00% | -76.9% |
| Q4 2021 | $6,273,000 | +1352.1% | 271,546 | +1772.7% | 0.01% | +1200.0% |
| Q3 2021 | $432,000 | – | 14,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |